Literature DB >> 1575339

The effect of desflurane and isoflurane on cerebrospinal fluid pressure in humans with supratentorial mass lesions.

D A Muzzi1, T J Losasso, N M Dietz, R J Faust, R F Cucchiara, L N Milde.   

Abstract

Desflurane, a new volatile anesthetic, produces cerebral vasodilation. The purpose of this study was to compare the effects of 1 MAC desflurane with those of isoflurane on cerebrospinal fluid pressure (CSFP) in patients with supratentorial mass lesions and a mass effect on computerized tomography (CT scan). Twenty adult patients undergoing craniotomy for removal of supratentorial mass lesions were studied. Ten patients received desflurane and 10 patients received isoflurane. Prior to induction of anesthesia, a radial artery catheter was inserted and a 19-G needle was inserted into the lumbar subarachnoid space to measure CSFP. Baseline arterial blood gases and CSFP were measured with the patient awake and unmedicated. Anesthesia was induced with thiopental (6-9 mg/kg) and muscle relaxation achieved with vecuronium (0.2 mg/kg). The lungs of all patients were hyperventilated to achieve an arterial CO2 tension of 24-28 mmHg. Anesthesia was maintained with 1 MAC volatile anesthetic, either 7.0% desflurane or 1.2% isoflurane in an air:O2 mixture to maintain an inspired O2 fraction (FIO2) of 0.50. Patients were not administered any other anesthetic until the dura was incised. Mean arterial pressure was kept within 20% of the patient's mean ward values with the use of esmolol or phenylephrine. CSFP, mean arterial pressure, end-tidal CO2 concentration (PETCO2), hemoglobin O2 saturation, and cerebral perfusion pressure were recorded with the patient awake, immediately postinduction with thiopental, postintubation, after institution of the volatile anesthetic, and every 5 min until the dura was incised. There was no difference in the mean (+/- SD) awake CSFP between the desflurane (11 +/- 4 mmHg) and the isoflurane (10 +/- 2 mmHg) groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575339     DOI: 10.1097/00000542-199205000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Effects of sevoflurane and desflurane on otoacoustic emissions in humans.

Authors:  Gurcan Gungor; Pervin Bozkurt-Sutas; Ozge Gedik; Ahmet Atas; Rovnat Babazade; Mehmet Yilmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

Review 2.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Comparison of postoperative cognitive dysfunction with the use of propofol versus desflurane in patients undergoing surgery for clipping of aneurysm after subarachnoid hemorrhage.

Authors:  Nanish Sharma; Jyotsna Wig; Shalvi Mahajan; Rajeev Chauhan; Manju Mohanty; Hemant Bhagat
Journal:  Surg Neurol Int       Date:  2020-07-04

Review 4.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 5.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

6.  A comparison of 1 minimum alveolar concentration desflurane and 1 minimum alveolar concentration isoflurane anesthesia in patients undergoing craniotomy for supratentorial lesions.

Authors:  Karamehmet Yildiz; Cihangir Bicer; Recep Aksu; Kudret Dogru; Halit Madenoglu; Adem Boyaci
Journal:  Curr Ther Res Clin Exp       Date:  2011-04

7.  Comparison of intraoperative brain condition, hemodynamics and postoperative recovery between desflurane and sevoflurane in patients undergoing supratentorial craniotomy.

Authors:  Surya Kumar Dube; Mihir Prakash Pandia; Arvind Chaturvedi; Parmod Bithal; Hari Hara Dash
Journal:  Saudi J Anaesth       Date:  2015 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.